Thymosin alpha 1 (Tα1) is a well-recognized immune response modulator in a wide range of disorders, particularly infections and cancer. The bioinformatic analysis of public databases allows drug repositioning, predicting a new potential area of clinical intervention. We aimed to decipher the cellular network induced by Tα1 treatment to confirm present use and identify new potential clinical applications.
Matteucci, C., Argaw-Denboba, A., Balestrieri, E., Giovinazzo, A., Miele, M., D'Agostini, C., et al. (2018). Deciphering cellular biological processes to clinical application: a new perspective for Tα1 treatment targeting multiple diseases. EXPERT OPINION ON BIOLOGICAL THERAPY, 18(sup1), 23-31 [10.1080/14712598.2018.1474198].
Deciphering cellular biological processes to clinical application: a new perspective for Tα1 treatment targeting multiple diseases
Matteucci C.;Balestrieri E.;Giovinazzo A.;D'Agostini C.;Pica F.;Grelli S.;Paci M.;Sinibaldi Vallebona P.;Garaci E.;
2018-07-01
Abstract
Thymosin alpha 1 (Tα1) is a well-recognized immune response modulator in a wide range of disorders, particularly infections and cancer. The bioinformatic analysis of public databases allows drug repositioning, predicting a new potential area of clinical intervention. We aimed to decipher the cellular network induced by Tα1 treatment to confirm present use and identify new potential clinical applications.| File | Dimensione | Formato | |
|---|---|---|---|
|
2018.Deciphering cellular biological processes to clinical application a new perspective for T 1 treatment targeting multiple (1).pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Licenza:
Non specificato
Dimensione
1.36 MB
Formato
Adobe PDF
|
1.36 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
